BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15030573)

  • 41. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
    Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
    Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma.
    van Rijt LS; Vos N; Willart M; Kleinjan A; Coyle AJ; Hoogsteden HC; Lambrecht BN
    J Allergy Clin Immunol; 2004 Jul; 114(1):166-73. PubMed ID: 15241361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
    Le Bon A; Etchart N; Rossmann C; Ashton M; Hou S; Gewert D; Borrow P; Tough DF
    Nat Immunol; 2003 Oct; 4(10):1009-15. PubMed ID: 14502286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of lung dendritic cells and B cells in stimulating naive antigen-specific T cells.
    Masten BJ; Lipscomb MF
    J Immunol; 1999 Feb; 162(3):1310-7. PubMed ID: 9973384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
    Schrader CE; Stavnezer J; Kikutani H; Parker DC
    J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
    Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
    Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dendritic cells in germ-free and specific pathogen-free mice have similar phenotypes and in vitro antigen presenting function.
    Walton KL; He J; Kelsall BL; Sartor RB; Fisher NC
    Immunol Lett; 2006 Jan; 102(1):16-24. PubMed ID: 16105690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD4 T cells integrate signals delivered during successive DC encounters in vivo.
    Celli S; Garcia Z; Bousso P
    J Exp Med; 2005 Nov; 202(9):1271-8. PubMed ID: 16275764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
    Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
    J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of dendritic cells with regulatory properties.
    Ureta G; Osorio F; Morales J; Rosemblatt M; Bono MR; Fierro JA
    Transplant Proc; 2007 Apr; 39(3):633-7. PubMed ID: 17445563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.
    Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response.
    Calderhead DM; DeBenedette MA; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
    J Immunother; 2008 Oct; 31(8):731-41. PubMed ID: 18779746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD4+ T cell acquisition of the bystander pMHC I colocalizing in the same immunological synapse comprising pMHC II and costimulatory CD40, CD54, CD80, OX40L, and 41BBL.
    He T; Zong S; Wu X; Wei Y; Xiang J
    Biochem Biophys Res Commun; 2007 Nov; 362(4):822-8. PubMed ID: 17803957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
    Dell K; Klein C; Gissmann L
    Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
    Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
    Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-species costimulation: relative contributions of CD80, CD86, and CD40.
    Rogers NJ; Jackson IM; Jordan WJ; Hawadle MA; Dorling A; Lechler RI
    Transplantation; 2003 Jun; 75(12):2068-76. PubMed ID: 12829914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice.
    Kai H; Shibuya K; Wang Y; Kameta H; Kameyama T; Tahara-Hanaoka S; Miyamoto A; Honda S; Matsumoto I; Koyama A; Sumida T; Shibuya A
    Immunology; 2006 Jun; 118(2):233-9. PubMed ID: 16771858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
    Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
    Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.